Resveratrol Represses Pokemon Expression in Human Glioma Cells

Yutao Yang1, Jiajun Cui2, Feng Xue3

  • 1Department of Neurobiology, Beijing Key Laboratory of Neural Regeneration and Repair, Beijing Laboratory of Brain Disorders (MOST), Beijing Institute for Brain Disorders, Capital Medical University, Beijing, 100069, China. yutaoy@ccmu.edu.cn.

Molecular Neurobiology
|April 16, 2015
PubMed

Insights

Resveratrol (RSV) inhibits glioma progression by decreasing Pokemon expression. Overexpressing Pokemon counteracts RSV

Area of Science:

  • Oncology
  • Molecular Biology
  • Neuroscience

Background:

  • POK erythroid myeloid ontogenic factor (Pokemon) is a proto-oncoprotein and transcriptional repressor implicated in tumorigenesis.
  • Resveratrol (RSV), a natural polyphenol, exhibits various health benefits, including potential anti-cancer properties.

Purpose of the Study:

  • To investigate the role of Pokemon in Resveratrol-induced biological effects in glioma cells.
  • To determine the effect of Resveratrol on Pokemon expression and its regulatory mechanisms in glioma.

Main Methods:

  • Investigated the impact of Pokemon overexpression on RSV-induced apoptosis, senescence, and proliferation.
  • Assessed RSV's effect on Pokemon promoter activity and expression.
  • Analyzed Sp1 DNA binding activity, HDAC1, and p300 recruitment to the Pokemon promoter.

Main Results:

  • Pokemon overexpression diminished RSV's anti-cancer effects (apoptosis, senescence, anti-proliferation).
  • RSV significantly reduced Pokemon promoter activity and Pokemon expression.
  • RSV inhibited Sp1 DNA binding to the Pokemon promoter without altering Sp1 expression or nuclear translocation.
  • RSV modulated histone modifiers, increasing HDAC1 and decreasing p300 recruitment to the Pokemon promoter.

Conclusions:

  • RSV exerts anti-cancer effects in glioma cells, partly through the downregulation of Pokemon.
  • RSV's mechanism involves inhibiting Pokemon promoter activity and modulating epigenetic regulators like HDAC1 and p300.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K